Recro Pharma Inc
(REPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REPH | IKT | CRDL | ||
| Company | Recro Pharma Inc | Inhibikase Therapeutics Inc | Cardiol Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.07 | 1.6400 | 0.9900 | ||
| High | 2.14 | 1.7250 | 1.0599 | ||
| Low | 2.00 | 1.6400 | 0.9801 | ||
| Latest | 2.09 | 1.6700 | 1.0400 | ||
| Change | -0.01 | +0.0300 | +0.0200 | ||
| % Change | -0.48% | +1.83% | +1.96% | ||
| Volume | 141,800 | 225,700 | 176,500 | ||
| 20-Day Average Volume | 122,300 | 682,425 | 379,540 | ||
| Previous Close | 2.10 | 1.6400 | 1.0200 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.84 | 1.6435 | 1.0146 | ||
| 20-Day Raw Stochastic | 85.07% | 46.75% | 64.71% | ||
| 20-Day Relative Strength | 65.13 | 50.38 | 52.67 | ||
| Weighted Alpha | -25.90 | -25.46 | -13.15 | ||
| Today's Opinion | 40% Buy | Hold | 24% Sell | ||
| Previous Opinion | 40% Buy | 32% Sell | 40% Sell | ||
| Last Month's Opinion | 56% Sell | 24% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.18% since 03/14/22 | -1.76% since 02/06/26 | +4.54% since 02/06/26 | ||
| Low | 1.94 on 03/15/22 | 1.5700 on 02/11/26 | 0.9801 on 02/13/26 | ||
| High | 2.19 on 03/18/22 | 1.7250 on 02/13/26 | 1.1000 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | +30.62% since 02/18/22 | -0.60% since 01/13/26 | +6.95% since 01/13/26 | ||
| Low | 1.52 on 02/24/22 | 1.4900 on 02/02/26 | 0.9300 on 02/02/26 | ||
| High | 2.19 on 03/18/22 | 1.8750 on 01/22/26 | 1.1000 on 02/10/26 | ||
| 3-Month | |||||
| %Chg | +35.71% since 12/21/21 | +4.37% since 11/13/25 | +1.96% since 11/13/25 | ||
| Low | 1.42 on 01/31/22 | 1.4000 on 12/03/25 | 0.8800 on 12/01/25 | ||
| High | 2.19 on 03/18/22 | 2.1591 on 01/05/26 | 1.1200 on 12/10/25 | ||
| 6-Month | |||||
| %Chg | +1.95% since 09/21/21 | -2.34% since 08/13/25 | -6.31% since 08/13/25 | ||
| Low | 1.38 on 12/06/21 | 1.3300 on 11/03/25 | 0.8800 on 12/01/25 | ||
| High | 2.20 on 09/23/21 | 2.1591 on 01/05/26 | 1.4199 on 08/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 117,926 | 125,542 | 116,147 | ||
| Shares Outstanding, K | 56,424 | 75,175 | 111,680 | ||
| Annual Sales | 75,360,000 | 0 | 0 | ||
| Annual Net Income | -11,370,000 | -27,520,000 | -26,770,000 | ||
| Last Quarter Sales | 22,300,000 | 0 | 0 | ||
| Last Quarter Net Income | -2,360,000 | -11,930,000 | -7,230,000 | ||
| 60-Month Beta | 1.08 | 0.84 | 1.04 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.13 on 11/14/25 | -0.09 on 11/13/25 | ||
| Latest Earnings Date | 05/05/22 | 03/26/26 | 03/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||